Review

Target-specific Oral Anticoagulants in the Emergency Department.

J Emerg Med. 2016 Feb 1; 50 (2): 246-57.
Review

Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols.

Am J Emerg Med. 2016 Nov 1; 34 (11S): 46-51.
Review

Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.

J Clin Pharm Ther. 2014 Apr 1;39(2):118-35.